Rheumatology

Secukinumab shows high drug survival and sustained effectiveness in psoriatic arthritis patients, with better outcomes in mixed peripheral and axial involvement.

A study of over 1,700 psoriatic arthritis patients across nine European countries reveals that tumor necrosis factor inhibitors (TNFi) work differently depending on the affected joint.

A new study has found a causal link between rheumatoid arthritis and an increased risk of prostate cancer, highlighting the role of chronic inflammation in cancer development.

A new study has found strong genetic evidence that air pollution can significantly increase the risk of autoimmune diseases, including rheumatoid arthritis and lupus.

A new study shows that biologic treatments significantly reduce inflammation and improve jaw function in children with juvenile idiopathic arthritis (JIA) affecting the temporomandibular joint (TMJ).

A study using the KOBIO registry reveals a 39 per 1,000 person-year infection rate in ankylosing spondylitis (AS) patients receiving biologics. Respiratory tract infections and herpes zoster were the most common, with age, diabetes, and kidney disease among key risk factors.

A groundbreaking analysis of the ESTHER trial reveals that resolution of MRI-detected inflammation in the sacroiliac joints is strongly linked to improved clinical outcomes in patients with axial spondyloarthritis undergoing long-term anti-TNF therapy.

A study from the KHOALA cohort reveals that body composition plays a critical role in the quality of life for patients with knee and hip osteoarthritis.